Evidence map›Paper›PMID 28082856›Full record

ArticlePhytochemistry reviews : proceedings of the Phytochemical Society of Europe2016

Chemical diversity and pharmacological significance of the secondary metabolites of nutmeg (

Ehab A Abourashed, Abir T El-Alfy

Open access · greenAbstract read
In one paragraph

Article in Phytochemistry reviews : proceedings of the Phytochemical Society of Europe, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Article
  3. Multi-stage insecticide potentials ofCurrent research in parasitology & vector-borne diseases · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. A new herbal anesthetic agent for common carp (Frontiers in veterinary science · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Survivability ofJournal of advanced veterinary and animal research · 2023
    Article
  19. Essential Oils and Neuropathic Pain.Plants (Basel, Switzerland) · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ehab A AbourashedDepartment of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, Chicago, IL 60628.
Abir T El-AlfyDepartment of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, Chicago, IL 60628.
Chicago State University · US

Funding

Urban Mindfulness and Addictions ResearchR24DA036410 · NIDA · CHICAGO STATE UNIVERSITY · PI EL-ALFY, ABIR T · 2013 to 2016
$1.7M
NIDA NIH HHS R24 DA036410
6 · The paper itself

Abstract

Nutmeg is a valued kitchen spice that has been used for centuries all over the world. In addition to its use in flavoring foods and beverages, nutmeg has been used in traditional remedies for stomach and kidney disorders. The antioxidant, antimicrobial and central nervous system effects of nutmeg have also been reported in literature. Nutmeg is a rich source of fixed and essential oil, triterpenes, and various types of phenolic compounds. Many of the secondary metabolites of nutmeg exhibit biological activities that may support its use in traditional medicine. This article provides an overview of the chemistry of secondary metabolites isolated from nutmeg kernel and mace including common methods for analysis of extracts and pure compounds as well as recent approaches towards total synthesis of some of the major constituents. A summary of the most significant pharmacological investigations of potential drug leads isolated from nutmeg and reported in the last decade is also included.

Indexed as

Biological evaluationChromatographic analysisDiarylalkanesLignans/neolignansNutmegPhenylpropanoidsTerpenes

Identifiers

PMID28082856
PMCPMC5222521
OpenAlexW2385872419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.